Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mancuso

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Tumori|July 1, 1996
A general overview of the process of carcinogenesisS Parodi, T Mancuso
Science (New York, N.Y.)|February 1, 1974
Beryllium diseaseJ D Stoeckle, T Mancuso
Current Oncology (Toronto, Ont.)|May 3, 2018
Ataxia-telangiectasia gene (<i>ATM</i>) mutation heterozygosity in breast cancer: a narrative reviewK J Jerzak, T Mancuso, A Eisen
Bollettino Della Societa Italiana Di Biologia Sperimentale|December 1, 1993
Oncosuppressor genes: mechanisms of inactivation for the retinoblastoma gene and p53L Clerico, T Mancuso, D Noonan, et al.
Science (New York, N.Y.)|July 28, 1978
Beryllium: carcinogenicity studiesJ K Wagoner, P F Infante, T Mancuso
Journal of Toxicology and Environmental Health. Part A|September 9, 1999
Liver mitochondria alterations in chloroform-treated Sprague-Dawley ratsC Guastadisegni, M Balduzzi, M T Mancuso, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|January 1, 1991
[The prevention of allergic diseases in 174 children "at risk" for atopy]G Bruno, P G Giampietro, R Nisini, et al.
Nucleic Acids Research|September 15, 1997
Mutation frequencies at codon 248 of the p53 tumour suppressor gene are not increased in colon cancer cell lines with the RER+ phenotypeT Mancuso, F Aguilar, M P Pescarolo, et al.
Mutation Research|June 13, 1997
Methods for predicting carcinogenic hazards: new opportunities coming from recent developments in molecular oncology and SAR studiesM Taningher, D Malacarne, T Mancuso, et al.
Minerva Medica|May 12, 1979
[Effects of intravenous lipid loading on HGH secretion after administration of L-DOPA]A Carducci Artenisio, F Ragonese, A Alibrando, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Tumori|July 1, 1996
A general overview of the process of carcinogenesisS Parodi, T Mancuso
Science (New York, N.Y.)|February 1, 1974
Beryllium diseaseJ D Stoeckle, T Mancuso
Current Oncology (Toronto, Ont.)|May 3, 2018
Ataxia-telangiectasia gene (<i>ATM</i>) mutation heterozygosity in breast cancer: a narrative reviewK J Jerzak, T Mancuso, A Eisen
Bollettino Della Societa Italiana Di Biologia Sperimentale|December 1, 1993
Oncosuppressor genes: mechanisms of inactivation for the retinoblastoma gene and p53L Clerico, T Mancuso, D Noonan, et al.
Science (New York, N.Y.)|July 28, 1978
Beryllium: carcinogenicity studiesJ K Wagoner, P F Infante, T Mancuso
Journal of Toxicology and Environmental Health. Part A|September 9, 1999
Liver mitochondria alterations in chloroform-treated Sprague-Dawley ratsC Guastadisegni, M Balduzzi, M T Mancuso, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|January 1, 1991
[The prevention of allergic diseases in 174 children "at risk" for atopy]G Bruno, P G Giampietro, R Nisini, et al.
Nucleic Acids Research|September 15, 1997
Mutation frequencies at codon 248 of the p53 tumour suppressor gene are not increased in colon cancer cell lines with the RER+ phenotypeT Mancuso, F Aguilar, M P Pescarolo, et al.
Mutation Research|June 13, 1997
Methods for predicting carcinogenic hazards: new opportunities coming from recent developments in molecular oncology and SAR studiesM Taningher, D Malacarne, T Mancuso, et al.
Minerva Medica|May 12, 1979
[Effects of intravenous lipid loading on HGH secretion after administration of L-DOPA]A Carducci Artenisio, F Ragonese, A Alibrando, et al.
Pageof 3